Clinical Trial Update: American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dronedarone for maintaining sinus rhythm in patients with atrial fibrillation or atrial flutter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED